HCA Healthcare
Q1 2022 Earnings Call
Apr 22, 2022, 10:00 a.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Welcome to the HCA Healthcare First Quarter 2022 Earnings Conference Call. Today's call is being recorded. At this time for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mr. Frank Morgan.
Please go ahead, sir.
Frank Morgan -- Vice President, Investor Relations
Good morning and welcome to everyone. Today's call with me this morning is our CEO, Sam Hazen and CFO, Bill Rutherford. Sam and Bill will provide some prepared remarks and then we'll take questions. Before I turn the call over to Sam.
Let me remind everyone that should today's call contain any forward-looking statements that are based on management's current expectations, numerous risks, uncertainties and other factors may cause actual results to differ materially from those they might be expressed today. More information on forward-looking statements, and these factors are listed in today's press release and in our various SEC filings. All in this morning's call, we may make a reference measure such as adjusted EBITDA, which is a non-GAAP financial measure. A table providing supplemental information on adjusted EBITDA and reconciling net income attributable to HCA Healthcare Inc.
is included in today's release. This morning's call is being recorded and a replay of the call will be available later today. With that, I'll now turn the call over to Sam.
Sam Hazen -- Chief Executive Officer
Good morning and thank you for joining our call. The Covid-19 pandemic continued to influence our results in the first quarter with the American surge, which slowed in the middle of the quarter. More significantly, the challenging labor market pressured margins as the cost of labor increased more than we expected as compared to the first quarter of the prior-year. In the face of these challenges, however, we had a number of positive volume and revenue indicators that were encouraging compared to the first quarter prior-year.
Same facility admissions increased 2%. During the quarter, we provided care to approximately 49,000 Covid-19 in-patients, which represented approximately 10% of total admissions consistent with prior-year. Non-Covid admissions grew 2.2%. This growth occurred in February and March.
In-patient surgeries grew approximately 1%, and across our in-patient business, acuity levels and payer mix continued to be strong. Outpatient volumes also rebounded strongly in the quarter. Same facility emergency room visits grew 15%. Same facility, outpatient surgeries grew nearly 7%.